FY2026 Earnings Estimate for Plexus Issued By Zacks Research

Plexus Corp. (NASDAQ:PLXS) – Stock analysts at Zacks Research boosted their FY2026 earnings per share estimates for Plexus in a research report issued to clients and investors on Wednesday, August 12th. Zacks Research analyst Team now anticipates that the technology company will earn $7.02 per share for the year, up from their previous estimate of $5.87. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Plexus’ current full-year earnings is $6.73 per share. Zacks Research also issued estimates for Plexus’ Q4 2026 earnings at $2.22 EPS, Q1 2027 earnings at $2.05 EPS, Q2 2027 earnings at $2.04 EPS, Q3 2027 earnings at $2.16 EPS, Q4 2027 earnings at $2.26 EPS, FY2027 earnings at $8.50 EPS, Q1 2028 earnings at $2.26 EPS, Q2 2028 earnings at $2.26 EPS, Q3 2028 earnings at $2.38 EPS and FY2028 earnings at $9.42 EPS.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.13 by $0.19. The firm had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.23 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The business’s revenue for the quarter was up 28.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS.

A number of other analysts also recently commented on the company. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target on the stock in a report on Friday, July 31st. Raymond James Financial reissued an “outperform” rating and issued a $275.00 price objective on shares of Plexus in a report on Thursday, April 30th. Needham & Company LLC upped their price target on Plexus from $285.00 to $310.00 and gave the company a “buy” rating in a research report on Monday, June 1st. Finally, Weiss Ratings lowered Plexus from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $273.00.

Plexus Trading Down 2.9%

Shares of PLXS stock opened at $264.04 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.72 and a current ratio of 1.49. The company has a market capitalization of $7.06 billion, a price-to-earnings ratio of 38.94 and a beta of 0.90. Plexus has a 52-week low of $126.86 and a 52-week high of $307.06. The company has a 50-day simple moving average of $272.53 and a two-hundred day simple moving average of $240.12.

Insider Transactions at Plexus

In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction on Wednesday, June 17th. The stock was sold at an average price of $294.98, for a total transaction of $442,470.00. Following the completion of the transaction, the chief executive officer owned 68,888 shares in the company, valued at approximately $20,320,582.24. The trade was a 2.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael J. Running sold 510 shares of Plexus stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $272.17, for a total value of $138,806.70. Following the completion of the transaction, the insider directly owned 665 shares of the company’s stock, valued at approximately $180,993.05. This represents a 43.40% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 9,510 shares of company stock valued at $2,625,182 in the last three months. 1.78% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Plexus

A number of hedge funds have recently added to or reduced their stakes in the company. AQR Capital Management LLC boosted its position in shares of Plexus by 103.1% during the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock valued at $1,074,000 after buying an additional 4,255 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Plexus by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock worth $2,046,000 after buying an additional 705 shares during the last quarter. United Services Automobile Association purchased a new position in shares of Plexus in the 1st quarter worth $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Plexus by 12.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock worth $10,197,000 after acquiring an additional 9,078 shares during the period. Finally, Cetera Investment Advisers purchased a new stake in Plexus during the second quarter valued at $309,000. 94.45% of the stock is currently owned by hedge funds and other institutional investors.

Plexus News Summary

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Zacks sharply raised earnings forecasts. Zacks lifted its FY2026 EPS estimate to $7.02 from $5.87, FY2027 to $8.50 from $6.55, and FY2028 to $9.42 from $8.31. The firm also increased several quarterly forecasts, including Q4 2026 EPS to $2.22 from $1.45 and Q3 2027 EPS to $2.16 from $1.49. These revisions signal stronger expected profitability and support the bullish case for PLXS. Earnings Estimates Rising for Plexus
• Positive Sentiment: Recent operating results exceeded expectations. Plexus reported quarterly EPS of $2.32 versus the $2.13 consensus estimate, while revenue reached $1.30 billion, above the $1.23 billion forecast and up 28.2% year over year. The company also issued Q4 2026 EPS guidance of $2.47–$2.63.
• Positive Sentiment: Analyst sentiment remains favorable. Plexus carries a consensus “Buy” rating, with recent target increases including Stifel’s $330 target and Needham’s $310 target. Institutional ownership is also high at approximately 94.45%.
• Negative Sentiment: A director sold $1.1 million of stock. Director Michael Schrock sold 4,000 shares at $275, reducing his holdings by 9.02%. The transaction occurred under a pre-arranged Rule 10b5-1 plan, which makes it a less concerning signal, but it may still weigh on sentiment. Insider Selling: Plexus Director Sells Stock

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.